Similar Papers

Paper Title
Journal
Date
Author
Assessment of lymphovascular invasion in early stage endometrial carcinoma -a retrospective study
Ambreen Moatasim ... Imran Ahmad
Surgical and Experimental Pathology | VOL. 4
Ambreen Moatasim, et. al.Ambreen Moatasim ... Imran Ahmad
12 Apr 2021
Abstract 5301: Integrative protein-marker prognostic model for early-stage endometrioid endometrial carcinoma
Han Liang
Cancer Research | VOL. 75
Han LiangHan Liang
01 Aug 2015
Data from Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
Remi A Nout ... Jan J Jobsen
-
Remi A Nout, et. al.Remi A Nout ... Jan J Jobsen
31 Mar 2023
Data from Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
Tjalling Bosse ... Vincent T.H.B.M Smit
-
Tjalling Bosse, et. al.Tjalling Bosse ... Vincent T.H.B.M Smit
31 Mar 2023
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma
Josephine G.M Strijker ... Judith Wienke
European Journal of Cancer | VOL. -
Josephine G.M Strijker, et. al.Josephine G.M Strijker ... Judith Wienke
01 Jan 2025
Editorial Board
-
European Journal of Cancer | VOL. 215
--
01 Jan 2025
The prognostic and clinical significance of substantial lymphovascular space invasion in early-stage endometrial carcinoma
Zhuang Li ... Aijun Yin
European Journal of Cancer | VOL. -
Zhuang Li, et. al.Zhuang Li ... Aijun Yin
01 Jan 2025
Characteristics and outcomes in patients with lenalidomide-refractory multiple myeloma treated with 1-3 prior lines of therapy: analysis of individual patient-level data from daratumumab clinical trials
Kwee Yong ... Binod Dhakal
European Journal of Cancer | VOL. 215
Kwee Yong, et. al.Kwee Yong ... Binod Dhakal
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.